Overview
Hui-ching Cheng practices in Tainan, Taiwan. Cheng is rated as an Advanced expert by MediFind in the treatment of Erythrokeratodermia Variabilis et Progressiva. Their top areas of expertise are Erythrokeratodermia Variabilis et Progressiva, Palmoplantar Keratoderma, Acrokeratoelastoidosis of Costa, Papillon-Lefevre Syndrome, and Vertebroplasty.
Their clinical research consists of co-authoring 29 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Erythrokeratodermia Variabilis et Progressiva.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acrokeratoelastoidosis of Costa
- Erythrokeratodermia Variabilis et Progressiva
- Palmoplantar Keratoderma
- Experienced
- Cardiomyopathy Due to Anthracyclines
- Dengue FeverCheng isExperienced. Learn about Dengue Fever.
- Doxorubicin-Induced Cardiomyopathy
- Generalized Pustular Psoriasis (GPP)
- Junctional Epidermolysis Bullosa
- Papillon-Lefevre SyndromeCheng isExperienced. Learn about Papillon-Lefevre Syndrome.